Ann: FDA clears Imugene IND for onCARlytics first-in-class study, page-108

I don't think this is going to be a mover. Only news the market seem to be interested in throwing money at are approvals or deals (happy to be wrong though). Someone with a fair parcel, or long term disgruntled holders, are happy to prevent any momentum, so no new money is likely going to jump in to see the price stagnate or drop further. Today's news is excellent, and is the exact kind of positive endorsement I think we can expect to see in the future.

As long as you are happy to have your money tied up in a stock that may not move for a while, then the future is bright.

There are countless examples of stocks that have stagnated or not moved for months and years before they absolutely take off once everyone is looking for a chair to sit on.

What is it that they say, time in the market, not timing the market. Speaks volumes to stocks like this. Can have arguments on daily prices until the cows come home, but at the end of the day, it's not going to matter if this turns out to be the bees knees in a $400b solid tumor market.